Payer PolicyActive
CMM-204: Prolotherapy
EVICORE-MSK_ADVANCED-5B905208
EviCore by Evernorth
Effective: February 14, 2020
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Prolotherapy (CPT M0076) is considered experimental, investigational, and unproven for musculoskeletal pain or instability (cited due to lack of conclusive evidence and potential adverse effects) and is not covered. No covered ICD‑10 diagnoses or documentation requirements are provided; final reimbursement/authorization is determined by the individual health plan’s benefit and claims rules.
Coverage Criteria Preview
Key requirements from the full policy
"None. The guideline does NOT identify any covered indications."
Sign up to see full coverage criteria, indications, and limitations.